​

Funding Round

Series A - Epitel

Series A - Epitel

Investment Firm

Overview

Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.

Announced Date

Feb 16, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Genoa Ventures

Genoa Ventures

Genoa Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Catalyst Health Ventures

Catalyst Health Ventures

Catalyst Health Ventures is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

6

Investor Name
Participant InvestorDexcom Ventures
Participant InvestorCatalyst Health Ventures
Participant InvestorGenoa Ventures
Participant InvestorWavemaker 360
Participant InvestorSLC Angels

Round Details and Background

Epitel raised $12500000 on 2022-02-16 in Series A

Epitel is empowering clinicians, patients, and caregivers who live with or care for neurological disorders with wearables and powerful AI.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 20, 2016
Grant - Epitel
1-2.8M
Oct 29, 2019
Venture Round - Epitel
1-100.0K
Jul 01, 2014
Grant - Epitel
1-5.0M
Feb 16, 2022
Series A - Epitel
7-12.5M

Recent Activity

There is no recent news or activity for this profile.